pharma · Acne Vulgaris · Pruritus · VYNE
VYNE Therapeutics
VYNE Therapeutics trial registry — 37 ClinicalTrials.gov studies with program phase, status, and indication context.
520 U.S. Highway 22, Suite 204, Bridgewater, NJ 08807, US HQ
2003 Founded
47 Employees
Public company Type
VYNE · NYSE Ticker
Company details
- Status
- Public
- HQ
- 520 U.S. Highway 22, Suite 204, Bridgewater, NJ 08807, US
- Founded
- 2003
- Employees
- 47
- Programs
- 30
- Drugs
- 16
- Patents
- 7
VYNE Therapeutics clinical trials
Registry index of 37 ClinicalTrials.gov studies linked to VYNE Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
VYNE Therapeutics trial registry — 37 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for VYNE Therapeutics.
-
Topical Minocycline Foam FXFM244 — Phase 2
Clinical update -
Topical Minocycline Foam FXFM244 — Phase 2
Clinical update -
Topical Minocycline Foam FXFM244 — Phase 2
Clinical update -
Isotretinoin — Approved
Clinical update -
FDX104 (4% Doxycycline) — Phase 2
Clinical update -
5mg Serlopitant Tablets — Phase 3
Clinical update -
Serlopitant Tablet — Phase 2
Clinical update -
Serlopitant High Dose — Phase 2
Clinical update
Trial registry
-
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗ -
CT.gov ↗